324 related articles for article (PubMed ID: 21613002)
1. Quality of life in patients treated for advanced hypopharyngeal or laryngeal cancer.
Guibert M; Lepage B; Woisard V; Rives M; Serrano E; Vergez S
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):218-23. PubMed ID: 21613002
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of health-related quality of life with EORTC QLQ-C30 and QLQ-H&N35 in Romanian laryngeal cancer patients.
Dinescu FV; Ţiple C; Chirilă M; Mureşan R; Drugan T; Cosgarea M
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2735-40. PubMed ID: 26511987
[TBL] [Abstract][Full Text] [Related]
3. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation.
Hanna E; Sherman A; Cash D; Adams D; Vural E; Fan CY; Suen JY
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):875-9. PubMed ID: 15262766
[TBL] [Abstract][Full Text] [Related]
4. [The results and toxicity of organ preservation treatment for locoregionally advanced laryngeal and hypopharyngeal cancer].
Kiprian D; Kawecki A; Jarząbski A; Michalski W; Pawłowska-Sendułka B
Otolaryngol Pol; 2011; 65(5):363-8. PubMed ID: 22078287
[TBL] [Abstract][Full Text] [Related]
5. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
6. Quality assurance in head and neck surgical oncology: EORTC 24954 trial on larynx preservation.
Leemans CR; Tijink BM; Langendijk JA; Andry G; Hamoir M; Lefebvre JL;
Eur J Surg Oncol; 2013 Sep; 39(9):1013-8. PubMed ID: 23810332
[TBL] [Abstract][Full Text] [Related]
7. [Squamous cell carcinoma of the hypopharynx and larynx: evidence-based care].
Fayette J; Pointreau Y; Bourhis J; Lefebvre JL
Bull Cancer; 2014 May; 101(5):438-44. PubMed ID: 24886894
[TBL] [Abstract][Full Text] [Related]
8. [Quality of life after treatment of laryngeal carcinoma: surgery versus radiotherapy].
Schneider A; Guidicelli M; Stöckli SJ
Schweiz Med Wochenschr Suppl; 2000; 116():31S-34S. PubMed ID: 10780067
[TBL] [Abstract][Full Text] [Related]
9. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.
Lefebvre JL; Ang KK;
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1293-303. PubMed ID: 19306746
[TBL] [Abstract][Full Text] [Related]
10. Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer.
Szuecs M; Kuhnt T; Punke C; Witt G; Klautke G; Kramp B; Hildebrandt G
J Radiat Res; 2015 Jan; 56(1):159-68. PubMed ID: 25348250
[TBL] [Abstract][Full Text] [Related]
11. Long-term functional and quality of life evaluation after treatment for advanced pharyngolaryngeal carcinoma.
Metreau A; Louvel G; Godey B; Le Clech G; Jegoux F
Head Neck; 2014 Nov; 36(11):1604-10. PubMed ID: 24115115
[TBL] [Abstract][Full Text] [Related]
12. [Surgical management of aged patients with hypopharyngeal carcinoma and preservation of laryngeal function].
Zhang DG; Luan XY; Pan XL; Xie G
Ai Zheng; 2005 Nov; 24(11):1372-5. PubMed ID: 16552966
[TBL] [Abstract][Full Text] [Related]
13. [Proposal for the management of epithelial carcinoma of the larynx and hypopharynx].
Orv Hetil; 1989 Apr; 130(18):949-50. PubMed ID: 2726245
[No Abstract] [Full Text] [Related]
14. Quality of life in patients with larygeal/hypopharyngeal cancer following total/partial laryngectomy.
Filipovska-Mušanović M; Hodžić D; Hrnčić N; Hatibović H
Med Glas (Zenica); 2012 Aug; 9(2):287-92. PubMed ID: 22926365
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcome in patients undergoing surgery for carcinoma larynx and hypopharynx: a follow-up study.
Varghese BT; Sebastian P; Mathew A
Acta Otolaryngol; 2009 Dec; 129(12):1480-5. PubMed ID: 19922101
[TBL] [Abstract][Full Text] [Related]
16. Total pharyngolaryngectomy for squamous cell carcinoma of the hypopharynx: a review.
Bova R; Goh R; Poulson M; Coman WB
Laryngoscope; 2005 May; 115(5):864-9. PubMed ID: 15867655
[TBL] [Abstract][Full Text] [Related]
17. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
[TBL] [Abstract][Full Text] [Related]
18. [Induction chemotherapy and larynx preservation: is such practice useful?].
Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
[TBL] [Abstract][Full Text] [Related]
19. Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers.
Clayman GL; Weber RS; Guillamondegui O; Byers RM; Wolf PF; Frankenthaler RA; Morrison WH; Garden AS; Hong WK; Goepfert H
Arch Otolaryngol Head Neck Surg; 1995 Feb; 121(2):219-23. PubMed ID: 7840931
[TBL] [Abstract][Full Text] [Related]
20. Oncological results of surgical treatment versus organ-function preservation in larynx and hypopharynx câncer.
Calvas OIJ; Ramos DM; Matos LL; Kulcsar MAV; Dedivitis RA; Brandão LG; Cernea CR
Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1082-1089. PubMed ID: 29489975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
